PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
November 18, 2008Annals of the Rheumatic Diseases338 citationsOpen Access

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

RFRoy FleischmannJVJiří VencovskýRVRonald van Vollenhoven

Key Points

Key points are not available for this paper at this time.

Abstract

Nct00548834.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Fleischmann et al. (2008) studied this question.

synapsesocial.com/papers/69dc755924e766dc313593achttps://doi.org/10.1136/ard.2008.099291
Ask AI
Helpful
Bookmark
Share
View Full Paper